Rapport Therapeutics Inc (RAPP): Market Value

The Rapport Therapeutics, Inc. (RAPP) price chart with the 1.26 indicator is accompanied by compliance with basic sanitary standards for laboratory waste disposal. Market capitalization relies on the development of epilepsy treatments via receptor modulation. Rapport Therapeutics, Inc. (RAPP) dictates the cost of future solutions by utilizing targeted action on affected brain areas, which minimizes the risk of side effects and ensures consistently high demand for the therapy.

RAPP Rapport Therapeutics: Market Valuation in the range 06/08/2024 - 11/14/2026

Comprehensive metric breakdowns and analytics for Rapport Corp (RAPP)

- current price and projected stock value:

Stock Price Rapport Therapeutics|RAPP - Analyst Consensus Forecast

- stock exchange capitalization data:

Market Value Rapport Corp|RAPP - Full Business Value

- book value of equity indicators:

Net Assets per Single Share Rapport Therapeutics|RAPP - Net Asset Value|Market Value to Book Value Ratio rapportrx.com|RAPP - Total Asset Value of Company

- debt burden and liquidity indicators:

Total Debt to Capital Rapport Therapeutics, Inc.|RAPP - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Rapport Therapeutics, Inc.|RAPP - Company Aggregate Debts|Debt to Book Capitalization Ratio Rapport Corp|RAPP - Company Long-Term Loans and Borrowings|Company Short-Term Debt Rapport Therapeutics|Quick Ratio rapportrx.com

- business earnings and investment ratios data:

RAPP - Net Profit|Future Profit Rapport Therapeutics, Inc.|RAPP - Company Value to Net Income|Future Price to Earnings Rapport Pharma|RAPP - Growth-Adjusted P/E Ratio|EV/EBITDA Multiple Rapport Corp|RAPP - Profit before interest, taxes and amortization|Net earnings per share for the last 12 months Rapport Therapeutics|RAPP - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months rapportrx.com|RAPP - Earnings per share increase in current year|Net earnings per share growth forecast for next year Rapport Therapeutics, Inc.

- sales volume and revenue information:

RAPP - Company Total Revenue|Company Projected Revenue Rapport Therapeutics|RAPP - Price-to-Revenue Ratio|Price-to-Projected Revenue Ratio Rapport Corp

Fundamental company analysis:RAPP (Rapport Therapeutics)

Rapport Therapeutics, Inc. (RAPP) development of an innovative precision neurotherapy ecosystem for the treatment of epilepsy directly impacts the company's market capitalization, which is calculated as the product of the current share price and the total number of outstanding shares. This metric reflects the aggregate market value of the business, allowing investors to assess the issuer's fundamental stability and avoid the risks of purchasing an asset at the peak of the cycle.

Key competitors